DMD: Charting the Path for New Therapeutics and Better Care – Webinar Main Trailer

Dear colleagues and friends, We are pleased to announce the featured speakers for the upcoming 8th episode in WuXi AppTec rare disease webinar series this September 9, entitled "Duchenne Muscular Dystrophy: Charting the Path for New Therapeutics and Better Care." Co-organized with Parent Project Muscular Dystrophy (PPMD) and CureDuchenne, and supported by many other leading muscular dystrophy patient organizations around the world, this complimentary event will be aired at 8am - 10:30am PDT (11am -1:30pm EDT) and 7pm - 9:30pm PDT (10pm - 12:30am EDT), respectively, to honor the great efforts of global collaboration. We will send a replay link after the event to those who registered but couldn't stay through the entire webinar. Please click this link to register: https://bit.ly/3sGbhIA Confirmed Speakers: Rhonda Bassel-Duby, Professor, Department of Molecular Biology, University of Texas Southwestern Medical Center Michael Binks, VP & Head of Clinical Research in the Rare Disease Research Unit at Pfizer Filippo Buccella, Founder, Parent Project Italy APS Hui Cai, VP and Head of Content, WuXi AppTec Huigu Chen, President, Shanghai Jiai Myopathy Care Center, China Paula Clemens, Professor & Vice Chair, Neurology, University of Pittsburgh School of Medicine Yi Dai, Associate Professor, Department of Neurology, Peking Union Medical College Hospital, China Ashish Dugar, SVP & Global Head of Medical Affairs, Dyne Therapeutics Kevin Flanigan, Director, Center for Gene Therapy, Professor, Pediatrics & Neurology, Nationwide Children’s Hospital Timothy Franson, Principal, Faegre Drinker Consulting Pat Furlong, Founding President & CEO, Parent Project Muscular Dystrophy Nathalie Goemans, Professor, Neuromuscular Reference Centre for Children, Department of Pediatric Neurology, University Hospitals Leuven, Belgium Tali Kaplan, Co-Founder & CEO, Little Steps Association for Patients with Duchenne & Becker Muscular Dystrophy, Israel Jane Larkindale, VP, Clinical Sciences, PepGen Art Levin, CSO, Avidity Biosciences Xihua Li, Director, Department of Neuromuscular Disease, Children’s Hospital of Fudan University, China Sherena Loh, Director, Muscular Dystrophy Association (Singapore) Debra Miller, CEO & Founder, CureDuchenne Hawken Miller, Features Writer, BioNews Stanley Nelson, Professor of Human Genetics, Center for Duchenne Muscular Dystrophy, David Geffen School of Medicine at UCLA Richard Parad, Associate Professor of Pediatrics, Harvard Medical School, Department of Pediatric Newborn Medicine, Brigham and Women’s Hospital Stuart Peltz, Founder & CEO, PTC Therapeutics Richard Soll, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec Stacey Tay, Senior Consultant, Department of Paediatrics, Khoo Teck Puat - National University Children's Medical Institute, National University Hospital, Singapore